Addex Therapeutics (ADXN) EV to CFO (2020 - 2026)
Addex Therapeutics' (ADXN) quarterly EV to CFO came in at 4.53 in Q1 2026, down 5.82% year-over-year from 4.81 in Q1 2025, and up 27.62% quarter-over-quarter from 6.26 in Q4 2025.
Powered by 
Analysis
Addex Therapeutics (ADXN) EV to CFO (2020 - 2026) Analysis & Trends
Addex Therapeutics has disclosed EV to CFO across 7 years of filings, most recently posting 4.53 for Q1 2026.
- In Q1 2026, EV to CFO fell 5.82% year-over-year to 4.53; the TTM figure through Mar 2026 stood at 1.51 (up 44.92% YoY), while the FY2025 annual figure was 0.22, down 12.29% from the prior year.
- EV to CFO came in at 4.53 for Q1 2026 at Addex Therapeutics, up from 6.26 in the prior quarter.
- In the past five years, EV to CFO ranged from a high of 0.61 in Q4 2024 to a low of 119.26 in Q1 2022.
- Average EV to CFO over 5 years is 18.55, with a median of 6.26 recorded in 2025.
- Year-over-year, EV to CFO surged 791.58% in 2024 and plunged 3182.57% in 2025.
- Over 5 years, EV to CFO stood at 5.14 in 2022, then soared by 101.32% to 0.07 in 2023, then jumped by 791.58% to 0.61 in 2024, then plunged by 1133.05% to 6.26 in 2025, then increased by 27.62% to 4.53 in 2026.
- Per Business Quant data, the three most recent EV to CFO figures were 4.53 in Q1 2026, 6.26 in Q4 2025, and 7.48 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Addex Therapeutics | 3.27 Mn | 3.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -4.53 |
| Dec 31, 2025 | -6.26 |
| Sep 30, 2025 | -7.48 |
| Jun 30, 2025 | -9.67 |
| Mar 31, 2025 | -4.28 |
| Dec 31, 2024 | 0.61 |
| Sep 30, 2024 | -4.74 |
| Jun 30, 2024 | -0.29 |
| Mar 31, 2024 | -2.41 |
| Dec 31, 2023 | 0.07 |
| Sep 30, 2023 | -20.59 |
| Jun 30, 2023 | -22.98 |
| Mar 31, 2023 | -53.49 |
| Dec 31, 2022 | -5.14 |
| Sep 30, 2022 | -32.39 |
| Jun 30, 2022 | -22.49 |
| Mar 31, 2022 | -119.26 |
| Dec 31, 2021 | -48.43 |
| Sep 30, 2021 | -288.42 |
| Jun 30, 2021 | -119.31 |